Microinjection of thyrotropin-releasing hormone analogue into the central nucleus of the amygdala stimulates gastric contractility in rats

The effect on gastric contractility following bilateral microinjection of thyrotropin-releasing hormone (TRH) analog. RX 77368, into the central nucleus of the amygdala was examined in fasted. urethane-anesthetized rats. Extraluminal force transducers were used to measure gastric corpus contractility. Bilateral microinjection of RX 77368 (0.5 μg. 1.0 μg,n = 6 each) stimulated gastric contractility for up to 120 min post-injection,P < 0.05. Gastric contractility was not significantly stimulated by microinjection of 0.1 μg RX 77368. 0.1% bovine serum albumin (BSA) into the central nucleus or RX 77368 (0.5 μg. 1.0 μg) into sites adjacent to the central nucleus. Peak responses (1.0 μg) occurred 40 min post-injection and represented a 16-26-fold increase over basal values. The frequency of gastric contraction waves was attenuated for 0–90 min in rats receiving central amygdaloid microinjection of RX 77368 (0.1. 0.5 or 1.0 μg) versus rats microinjected with the vehicle or RX 77368 into sites adjacent to the central nuclei. The stimulatory effect of RX 77368 (1.0 μg) on gastric contractility was abolished by subdiaphragmatic vagotomy. These results indicate that the TRH analog. RX 77368, acts within the central amygdala to vagally stimulate gastric contractility.